RANSS | ONSS | P value | ||
---|---|---|---|---|
Mean age (years) | 51.5 ± 13.4 (range = 30–76) | 58.5 ± 10.25 (range = 31–82) | 0.049 | |
Gender (female/male) | 9/23 | 8/15 | N.A. | |
Mean A.S.A. score | 1.47 ± 0.51 (range = 1–2) | 1.43 ± 0.59 (range = 1–3) | 0.819 | |
Mean tumor size (cm) | 4.25 ± 3.0 (range = 1.2-15) | 4.27 ± 2.27 (range = 0.5-9.5) | 0.976 | |
Tumor morphometry (mean values) | R.E.N.A.L. | 6.15 ± 2.04 (range = 4–10) | 8 ± 1.5 (range = 5–10) | 0.0006 |
P.A.D.U.A. | 7.53 ± 1.81 (range = 6–11) | 8.56 ± 1.44 (range = 6–11) | 0.027 | |
C-index | 1.49 ± 0.43 (range = 0.7-2) | 1.25 ± 0.5 (range = 0–2) | 0.066 | |
Mean operative duration (min) | 154.3 ± 55.3 (range = 70–270) | 126.09 ± 33.51 (range = 75–220) | 0.034 | |
Mean EBL (ml) | 189.1 ± 165.4 (range = 100–1000) | 239.13 ± 102.2 (range = 100–500) | 0.204 | |
Transfusion (n) | 5 (15.62%) | 1 (4.34%) | 0.383 | |
Hilar clamping (n) | 8 (25%) | 6 (26.08%) | 1.0 | |
Mean WIT (min) | 20.62 ± 2.19 (range = 16–24) | 16.50 ± 5.21 (range = 12–23) | 0.064 | |
Mean duration of hospitalization (days) | 4.06 ± 1.29 (range = 3–7) | 4.6 ± 1.75 (range = 3–10) | 0.188 | |
30-day Clavien grade ≥ 2 complications (n) | 6 (18.75%) | 4 (17.39%) | 0.988 |